# SAREPTA THERAPEUTICS, INC. (SRPT) FY2026 YTD Q2 Statement of Cash Flows

- Company: SAREPTA THERAPEUTICS, INC. (SRPT)
- Period: 2026-01-01 to 2026-06-30
- Filing: Q2 FY2026 10-Q, filed 2026-08-05, accession number 0001193125-26-335003
- Page: https://plicit.ai/financials/srpt/fy2026-ytd-q2-cash-flow
- Chart image: https://plicit.ai/charts/srpt-fy2026-ytd-q2-cash-flow-sankey.png

## Chart details

Cash flows for Jan 1, 2026 through Jun 30, 2026. Cash basis: Cash, cash equivalents, and restricted cash. Beginning cash: Dec 31, 2025. Ending cash: Jun 30, 2026. Beginning and ending cash are dated balances. Positive cash flows add cash; negative cash flows reduce it.

- **Beginning cash on Dec 31, 2025**: 814,407,000 US dollars. Beginning cash: Cash, cash equivalents, and restricted cash
- **Operating activities**: negative 5,613,000 US dollars. Net cash used.
- **Net income (loss)**: 326,069,000 US dollars
- **Loss on strategic investments**: 2,160,000 US dollars
- **Stock-based compensation**: 53,871,000 US dollars
- **Depreciation and amortization**: 21,003,000 US dollars
- **Non-cash inventory write-downs for obsolescence**: 11,599,000 US dollars
- **Non-cash interest expense**: 19,006,000 US dollars
- **Reduction in the carrying amounts of the right of use assets**: 6,322,000 US dollars
- **Accretion of investment discount, net**: negative 1,435,000 US dollars
- **Other**: negative 1,298,000 US dollars
- **Decrease (increase) in accounts receivable**: 21,409,000 US dollars
- **Decrease in manufacturing-related deposits and prepaids**: 69,279,000 US dollars
- **Increase in inventory**: negative 29,845,000 US dollars
- **Increase in other assets**: 67,840,000 US dollars
- **Decrease in deferred revenue**: negative 307,043,000 US dollars
- **Decrease in accounts payable**: negative 229,859,000 US dollars
- **(Decrease) increase in accrued expenses**: negative 37,331,000 US dollars
- **(Decrease) increase in lease liabilities and other liabilities**: 2,640,000 US dollars
- **Investing activities**: negative 227,762,000 US dollars. Net cash used.
- **Purchase of investments**: negative 351,045,000 US dollars
- **Purchase of property and equipment**: negative 2,636,000 US dollars
- **Maturity and sales of available-for-sale securities**: 126,919,000 US dollars
- **Purchase of intangible assets**: negative 1,000,000 US dollars
- **Acquisition of strategic investments**: 0 US dollars
- **Financing activities**: 241,000 US dollars. Net cash provided.
- **Proceeds from exercise of stock options and purchase of stock under the Employee Stock Purchase Program**: 241,000 US dollars
- **Proceeds from borrowings under the Revolving Credit Facility**: 425,000,000 US dollars
- **Repurchases of common stock**: 0 US dollars
- **Repayments of borrowings under the Revolving Credit Facility**: negative 425,000,000 US dollars
- **Payments related to obtaining Revolving Credit Facility**: 0 US dollars
- **Operating adjustment reconciliation**: 606,811,000 US dollars. Intermediate calculation joining the operating reconciliation branches. Its gross amount includes any portion of net income routed through this junction. It is not an additional cash source or use.
- **financing gross reconciliation**: 425,241,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **investing gross reconciliation**: 354,681,000 US dollars. Gross amount at the activity's junction before offsetting its receipts and deductions. It is not an additional cash source or use.
- **Exchange-rate effect**: 0 US dollars
- **Ending cash on Jun 30, 2026**: 581,273,000 US dollars. Ending cash: Cash, cash equivalents, and restricted cash
- **Cash sources and uses**: 814,648,000 US dollars. Opening cash plus net sources, equal to net uses plus ending cash.
- **Net cash change**: negative 233,134,000 US dollars. Ending cash minus beginning cash.
- **Cash flow / Net income**: −0.02×. Operating cash flow divided by reconciliation net income for the same period. Black from 0.90× through 1.10×; green above 1.10×; red below 0.90×. Color uses the unrounded ratio.
- **Operating cash flow**: negative 5,613,000 US dollars. Operating cash flow used in the free cash flow calculation.
- **Cash purchases of property, plant and equipment**: 2,636,000 US dollars. These cash purchases are already included in investing activities above.
- **Free cash flow**: negative 8,249,000 US dollars. A supplemental measure; finance-lease payments are excluded from this definition.

### Chart connections

- Beginning cash plus operating, investing and financing cash flows plus the exchange-rate effect equals ending cash. Negative amounts reduce cash.
- Financing contributions meet at a reconciliation junction before connecting to the net cash total.
- Investing contributions meet at a reconciliation junction before connecting to the net cash total.
- Operating reconciliation adjustments are not all independent cash receipts.
- Net income or operating cash is negative. The full signed reconciliation is retained: losses remain deductions, and any negative operating-cash total enters the junction from the cash pool. No positive direct-income connection is implied.
- Each activity has one net cash bar connected to the shared cash pool. Positive activity totals enter the pool; negative activity totals leave the pool to fund that activity's net payments. The central pool does not assign a particular funding source to a particular payment.
- The intermediate calculation bars include both sides of the displayed activity breakdowns; they are not additional cash flows.
- Operating cash flow minus cash purchases of property, plant and equipment equals free cash flow: negative 5,613,000 US dollars minus 2,636,000 US dollars equals negative 8,249,000 US dollars.